In recent trading session, PMV Pharmaceuticals Inc (NASDAQ:PMVP) saw 0.46 million shares changing hands at last check today with its beta currently measuring 1.55. Company’s recent per share price level of $1.91 trading at $0.04 or 2.41% at last check today assigns it a market valuation of $98.51M. That most recent trading price of PMVP’s stock is at a discount of -408.9% from its 52-week high price of $9.72 and is indicating a premium of 38.74% from its 52-week low price of $1.17. Taking a look at company’s average trading volume of 564.41K if we extend that period to 3-months.

PMV Pharmaceuticals Inc (NASDAQ:PMVP) trade information

Upright in the green today for gaining 2.41%, in the last five days PMVP remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $1.91 price level, adding 4.5% to its value on the day. PMV Pharmaceuticals Inc’s shares saw a change of -38.23% in year-to-date performance and have moved 9.43% in past 5-day. PMV Pharmaceuticals Inc (NASDAQ:PMVP) showed a performance of 19.69% in past 30-days.

PMV Pharmaceuticals Inc (PMVP) estimates and forecasts

Statistics highlight that PMV Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -3.28% of value to its shares in past 6 months, showing an annual growth rate of 0.00% while that of industry is 11.50.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -28.63% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 4.17% while estimates for its earnings growth in next 5 years are of 23.10%.

PMVP Dividends

PMV Pharmaceuticals Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.